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for neurosurgical resource allocation
Alexander F. C. Hulsbergen1,2 & Marleen M. Eijkholt1,3 & Naci Balak1 & Jannick Brennum1 & Ciarán Bolger1,4 &
Anna-Margarete Bohrer1 & Zeev Feldman1 & Daniel Holsgrove1 & Neil Kitchen1 & Tiit I. Mathiesen1,5,6,7 &
Wouter A. Moojen1,2 & Nicolás Samprón1,8 & Martin Sames1 & Ulrika Sandvik1,7 & Magnus Tisell1 &
Marike L. D. Broekman1,2
# The Author(s) 2020
Abstract
Background The COVID-19 pandemic confronts healthcare workers, including neurosurgeons, with difficult choices regarding
which patients to treat.
Methods In order to assist ethical triage, this article gives an overview of the main considerations and ethical principles relevant
when allocating resources in times of scarcity.
Results We discuss a framework employing four principles: prioritizing the worst off, maximizing benefits, treating patients
equally, and promoting instrumental value. We furthermore discuss the role of age and comorbidity in triage and highlight some
principles that may seem intuitive but should not form a basis for triage.
Conclusions This overview is presented on behalf of the European Association of Neurosurgical Societies and can be used as a
toolkit for neurosurgeons faced with ethical dilemmas when triaging patients in times of scarcity.
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Introduction—ethical reflection, why now?
A great shortage of healthcare capacity is looming over us as
the COVID-19 (SARS-CoV-2) crisis advances. While at the
time of writing, European countries seem to have overcome
the initial wave of cases, we are, in the words of German
Chancellor Angela Merkel, only at the start of the pandemic
[7]. In the future, economic and/or political pressure to allevi-
ate lockdown measures, combined with a risk of faltering
public compliance with long-term social distancing require-
ments, could cause new outbreaks. This creates a realistic
possibility of future waves in Europe or elsewhere, which
could put healthcare capacity under higher pressure still, either
in general or locally.
This may force healthcare workers into painstaking di-
lemmas. Most COVID-19-related triage befalls general prac-
titioners, internists, and intensivists; however, neurosurgeons,
too, will need to triage—first, because insufficient manpower
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of intensivists may call for other medical specialists to allevi-
ate their burden, and second, because the consequences of
scarcity will cascade down into non-COVID patients, includ-
ing those cared for by neurosurgeons. This “collateral dam-
age”, while typically not incorporated into COVID-19 death
tolls, may considerably append the true impact of this pan-
demic within the neurosurgical patient population.
While the adage “Sometimes wrong, never in doubt” as
described by Atul Gawande [4] eloquently describes both a
criticism and a strength of surgeons, the choices that need to
be made in times of scarcity can be extremely tragic and exert
great mental stress on even the most resilient of physicians.
Therefore, neurosurgical departments are encouraged to re-
flect on the ethical dimensions of their triaging policies up-
front. While some would argue that this is not the time for
ethics—perhaps perceived as long-winded theoretical
discourse—the contrary is true: never were the implications
of ethical judgments more practical than in times of crisis.
Anticipating ethical dilemmas before they happen will
save time when they arise and will ease the burden of
decision-making “in the field”. Lastly, adhering to pro-
spectively drawn up institutional, regional, or national
policies could shield healthcare workers from potential
future liability claims.
To help tailor individual triage-related decisions, the
Ethico-Legal Committee of the European Association of
Neurosurgical Societies presents an overview of ethical con-
siderations relevant for the allocation of medical resources,
which can be used as a toolkit by neurosurgeons faced with
these dilemmas.
Selecting patients in scarcity: which principles
can we build on?
The traditional pillars of medical ethics (beneficence, non-
maleficence, justice, and autonomy) may not provide suffi-
cient guidance in exceptional situations such as a pandemic;
they must be complemented by different criteria to guide al-
location of scarce resources in a crisis. One possible triage
framework has been proposed by Emanuel et al. (NEJM,
2020) [3]. Here, the authors promote allocation according to
four values: (1) giving priority to the worst off, (2) maximiz-
ing benefits yielded by scarce resources, (3) treating people
equally, and (4) promoting and rewarding instrumental value.
These four points can be applied in different situations
and have different advantages and disadvantages; an
overview is presented in Table 1. This framework is
not necessarily all-encompassing. For example, to max-
imize benefits, one still needs to decide whether this
constitutes maximizing the number of lives saved versus
the number of life-years saved. Below, the four points
will be discussed individually.
Giving priority to the worst off
A classical first line of triage determines which patients most
urgently need care. Questions that can be asked to make this
decision include the following:
1. Is the patient’s condition life-threatening? Will treatment
be (potentially) lifesaving? If so, what is the chance that it
will work?
2. If the patient’s condition is not life-threatening, will treat-
ment (potentially) prevent permanent damage? If so, what
is the chance that this will work?
3. If the treatment will not prevent permanent damage, will it
prevent or treat temporary damage? If so, how much and
what is the chance that treatment will work?
4. Can treatment be reasonably postponed? If so, how long?
Here, one should also take into consideration the expected
future capacity based on the distribution of COVID-19
burden over time.
In the context of ICU admission, the life-saving potential of
mechanical ventilation in different COVID-19 patient groups
is still uncertain. Some reports have demonstrated a high mor-
tality, especially in the elderly [5]. Departments are advised to
frequently keep track of institutional or published data to aid
decision-making in this respect.
Another dimension of complexity is added by COVID-19:
what if, due to infection, the patient leaves the hospital in a
worse state than their initial presentation? In line with the
principle of nonmaleficence, neurosurgeons have an obliga-
tion to assess the risk of infection and unfavorable clinical
course for patients who need to be operated, especially those
with risk factors such as advanced age. These risks should be
discussed with the patient when obtaining informed consent
preoperatively.
Maximizing benefits
Maximizing benefits can be interpreted as either saving the
most lives or the most life-years. Both of these approaches can
be justified. In scenarios were a certain number of lives could
be saved, say, because there is a certain number of ventilators
available, determination of life-years may help to triage be-
tween two or more patients who would both need one
ventilator.
Maximizing gained life-years: the role of age and comorbidity
Both a patient’s age and comorbidities play a role in determin-
ing potential treatment benefit. For example, older patients or
patients with severe comorbidity may have less long-term gain
from treatment, even if it is lifesaving in the short term. In the
proposed selection criteria, age and comorbidities play a
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Table 1 Simple principles and their ethical values for resource allocation
Application Advantages Disadvantages Examples in neurosurgery COVID-
application
Maximize total benefits
Number of lives saved Saves more lives; benefits the greatest
number
Ignores other relevant principles such
as sickest first or treating people
equally; requires medical
assessment
Two patients with EDH are
treated instead of one
patient with a complex
petroclival meningioma
*****
Life-years (maximize
survival prognosis)
Maximizes life-years Ignores other relevant principles;
requires medical assessment
*****
Good quality life years Maximizes quality of life-years, adds
dimensions of quality and quantity
Difficult to apply because of valid
prognostic factors; problematic
assessment of quality, who decides
and what is quality; risks random
application of cost-effectiveness
Two patients with early
herniation from EDH,
treating the person who will
return to active and
conscious life
^
Treat people equally
Lottery or random
selection
Facilitates distribution through easy
application, hard to corrupt, little
information about recipients
needed; free from medical
assessment
Ignores relevant principles such as
saving the maximum number of
lives, sickest first…
Clinical research subjects are
randomized to placebo or
active drug
^^
First-come,
first-served
Reflects daily practice; free from
medical assessment; little
information on recipients needed;
available resources are used according
to demand
Favors well-connected patients who
are likely to present first; ignores
other relevant principles like sickest
first, youngest first, maximizing
life-years.
Neuro-ICU beds go to those
who come first as long as
available
X
Favor the worst off
Sickest first Aids those who are suffering right
now; appeals to the “rule of rescue”
makes sense in temporary scarcity;
proxy for being worst off overall
Surreptitious use of prognosis; ignores
needs of those who will become sick
in future; might falsely assume
temporary scarcity; leads to people
receiving interventions only after
prognosis deteriorates; ignores
principles like life-years saved and
cost-efficiency
Patient with large acute SDH
in deep coma treated before
conscious EDH patient with
beginning herniation
^^^
Youngest first Benefits those who have had the least
life and experiencesa; prudent
planners have an interests in living
to old age
Undesirable priority to infants over
adolescents and young adults;
ignores other relevant principles.
Pediatric craniosynostosis
patients are operated before
adults who need
cranioplasty after
decompressive craniectomy
^^^
Promote and reward instrumental value (benefit to others)
Prospective- priority
to those who are
likely to make
relevant
contributions
Promotes continued work and care by
health-care personnel,
Vulnerable to abuse through choice of
prioritized occupations or activities;
can direct health resources away
from health needs.
Unfair to disadvantaged and could
represent misuse of power
Ventilator will go to
neurosurgeon over
accountant so he can treat
multiple brain tumor
patients with COVID
^^^
Retrospective-priority
to those who have
made relevant
contributions
Enables promises for those who have
contributed to research and
exposed themselves to risk (e.g.
COVID-19 research and care of
virus victims).
Vulnerable to abuse and exploitation;
can direct health resources away
from health needs; intrusive process
of what constitutes a worthy past-
contribution;
Brain tumor patient
volunteered as research
participant early in COVID
pandemic to examine
effects on the CNS
^^^
Adopted from Persad et al. [6]; based on the idea of “fair” innings as per Callahan D: Setting Limits [1]
*****Priority principle
^Principle to apply with caution: used only in obvious cases, together with other criteria, otherwise too complicated to apply
^^Principle to apply with caution: used for selecting among patients with similar prognosis
^^^Principle to apply with caution: use with maximizing benefits
X Principle should not be used
a Based on the idea of “fair innings” as per Callahan D: Setting Limits
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limited, though real, role in the selection. It should be noted
that elderly people or people with comorbidities do not prin-
cipally have less right to healthcare than their healthy, young
counterparts, and their life-years count equally. In other
words, one gained life year for an 80-year old is as valuable
as one gained life year in a 60-year-old cancer patient or a 30-
year-old healthy individual. It is therefore not ethical to cate-
gorically refuse medically meaningful treatment or intensive
care unit (ICU)/hospital admission for older patients, or pa-
tients that are impaired by significant comorbidities, against
their will. In practice however, younger and healthier individ-
uals will nearly always have the most life-years to gain, which
will benefit their triage.
Caution should be applied when making granular estima-
tions of life expectancy. While certain groups in society may
have a lower (healthy) life expectancy and, thus, perhaps few-
er life-years to gain, this stratification should not be used for
triage. Examples may include patients of racial minorities or
those of low socioeconomic status. Here, even if such a triage
could theoretically be explained by maximizing benefits, this
would hit already disadvantaged patient groups and endanger
the principle of justice.
What constitutes “significant comorbidity?”
Sometimes, comorbidity will be an obvious consideration in
triage. Patients with terminal and/or severely debilitating con-
ditions such as metastatic cancer, amyotrophic lateral sclero-
sis, Alzheimer’s disease, or advanced Parkinson’s disease
may have a relatively limited benefit from further treatments
when compared with others in situations of dire shortage.
Unfortunately, there is a very large gray area as to what con-
stitutes significant comorbidity. There is a broad scale of
chronic conditions, including common degenerative condi-
tions (metabolic syndrome, arthrosis, chronic obstructive pul-
monary disease), genetic/developmental diseases (autism, he-
mophilia, Down’s syndrome), or mental health conditions (de-
pression, bipolar disorder, schizophrenia) that may reduce
length or quality of life. Taking into account every co-
occurrent condition would lead to a draconian triage that again
disproportionally affects the already disadvantaged and
threatens the principle of justice. Moreover, it ignores the in-
herent uncertainty of survival prediction. On the other hand,
disregarding comorbidity entirely leads to ineffective triage.
This article does not aim to advise on where to draw the line,
but advises cautious use of comorbidity in triage, weighing
beneficence versus justice.
Quality of life after treatment
Beyond number of lives and life-years saved, expected quality
of life can be an important consideration when determining
the merit of treatment. Prolonging life of very low quality may
not be desirable, and therefore, quality of life could play a role
in triage. However, it should be noted that trying to make
granular estimations of quality of life has some considerable
limitations. First, we have no data on long-term quality of life
after (severe) COVID-19 pneumonia. Second, disease-
specific quality of life has a high interpersonal variability;
while perhaps measurable on a public health level and useful
for global burden of disease estimations, it will be near im-
possible to accurately assess for individual patients. Third,
even if these assessments were roughly feasible, they would
be time and resource consuming. Thus, quality of life should
only influence triage when there are large and obvious differ-
ences between patients.
Length of ICU stay
While individual length of ICU stay is hard to predict, data on
the average clinical course of ICU-admitted COVID-19 pa-
tients is increasingly becoming available [5]. Moreover, expe-
rienced neurosurgeons will be able to make educated estima-
tions of the expected necessity of and length of ICU stay for
neurosurgical patients. Length of ICU stay can be a consider-
ation in triage. While an extremely utilitarian approach would
be to construct a sort of “expected gain in life-years per day in
the ICU” metric, we believe such a tool is overly calculating
and is not justified for the same reasons granular estimations
of life-years and quality of life are unjust, as explained in the
previous paragraphs. However, when there are large differ-
ences in expected ICU stay between patients of otherwise
similar prognosis, this criterium could play a role in triage,
favoring patients who would need a considerably shorter
ICU stay to recover.
Treating people equally
In the setting of scarcity, two systems have been proposed to
operationalize this principle. Enabling allocation of resources
one could opt for a system that treats patients on a first come
first-basis, or on basis of a lottery. However, neither system
seems appropriate to serve as a sole triage tool.
To allocate treatment for patients by a ‘first come, first
served’ basis seems unwise. Such system would encourage
crowding or even violence near hospitals, as well as unfairly
benefit those living in the proximity of care centers.
Moreover, it may disadvantage those who happen to fall ill
further into the epidemic instead of in the beginning, perhaps
due to stricter adherence to social distancing recommenda-
tions [3]. A lottery system could be considered a system of
allocation, but only in limited circumstances. Its blinded
mechanism seems to offer certain advantages: it offers patients
an equal chance and requires little time or knowledge of pa-
tient’s history beforehand. However, when patients have very
different prognoses, randomization would not maximize
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benefits. Thus, lottery can be used, but only for patients with
roughly similar prognoses.
We would like to stress that in case of equal expected
benefit of care, patients with diseases other than COVID-19
have an equal right to healthcare as do COVID-19 patients.
Triage should therefore not be based on COVID-19 vs other
diagnoses but be open to all patients who might benefit from
scarce resources. One exception may be when not treating a
COVID-19 patient would lead to an elevated risk of contam-
ination of more patients that cannot be mitigated by quaran-
tine. If necessary, neurosurgeons should advocate for their
patients’ access to care and can use the other criteria in this
article determine when such access can be justified.
Promoting and rewarding instrumental value
Aperson’s benefits and value to the system is a very controversial
selection criterion. Generally, triaging decisions should not be
based on a patient’s potential benefit to society. Such “perceived
usefulness” can be a highly subjective judgments that physicians
are not well-equipped to make. Moreover, societal use as a crite-
rium for treatment priority has undesirable implications that
threaten the principle of justice and may again be particularly
unfair those with chronic diseases or mental/physical handicaps.
However, exceptions to this principle can be made. There
are strong arguments in favor of prioritization for healthcare
workers who could help patient care during the pandemic.
First, their hastened recovery will benefit future healthcare sys-
tem capacity and the ability to treat more patients in the short or
intermediate-term future. Second, it is arguably unfair to those
exposing themselves—perhaps even without adequate
protection—to the greatest risk of infection by helping others
if they have a low chance of receiving adequate treatment when
falling ill; this may also cause absenteeism among healthcare
workers [3]. Third, infected healthcare workers may become
“serial spreaders” infecting many patients they interact with.
This violates the ethical principle of non-maleficence and
should absolutely be avoided. Another exception could be
made those who have a direct responsibility for long-term care
of others, such as those caring for multiple people. While case-
to-case assessment is essential in this category, potential impact
on the quality of life for those dependent on the patient could be
taken into account. Lastly, patients and researchers who con-
tribute to critical COVID-19 research could be prioritized to
ensure the continuity of this research.
No-go allocation criteria
We furthermore want to discuss two selection criteria that might
be intuitive but that do not feature in Emmanuel’s list. We are
adamant that these should not be allocation criteria to use for
individual providers. First, triage should not be based on risk-
related behavior in patients. Recently, news media have featured
stories of people willfully ignoring national COVID-19-related
recommendations, or even displaying direct risk-seeking behav-
iors [2]. Indignation toward this is entirely understandable.
However, prioritizing care cannot be based on this sentiment.
This is comparable to how the right to healthcare for other con-
ditions, such as cancer and cardiovascular diseases, is not affect-
ed by a patient’s previous lifestyle and/or management of mod-
ifiable risk factors. Second, we do not deem it ethical under any
circumstances to triage patients based on wealth, insurance sta-
tus, or social status. In a broader sense, this also includes patient’s
immediate ability or willingness to pay, their societal role (be-
yond essential functions), caste, nationality, ethnicity, religion,
political conviction, gender, sexual orientation, or other personal
characteristics not discussed above.
Conclusion
COVID-19 may confront healthcare workers with extremely
difficult dilemmas, and no single algorithm can provide com-
plete guidance nor fully alleviate the heavy burden of triage.
Individual triage, including weighing beneficence against jus-
tice, is ultimately the responsibility of the treating physician
and should be tailored to a particular situation. The preferred
degree of application of different principles will vary across
Europe, and may depend on cultural and political climates.
This paper can be used as a toolkit to structure different con-
siderations that may come into play during such decision-
making. Neurosurgeons should strive to maximize benefits
of treatment in terms of good life for most, while also priori-
tizing justice in treatment allocation and protection of those
who hold key instrumental value.
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